Clare F Malone et al.
Cancer discovery, 7(12), 1450-1463 (2017-10-01)
Although agents that inhibit specific oncogenic kinases have been successful in a subset of cancers, there are currently few treatment options for malignancies that lack a targetable oncogenic driver. Nevertheless, during tumor evolution cancers engage a variety of protective pathways